Last edition
News about "Orphan Drug Designation "
Shanghai MicuRx's MRX-5 Receives FDA Orphan Drug Designation for NTM Infections
MRX-5 is a novel benzoxazole antibiotic developed for treating mycobacteria infections, particularly infections caused by non-tuberculous mycobacteria (NTM).
Orphan Drug Designation | 03/01/2025 | By Abha
Vanda Pharmaceuticals Receives Orphan Drug Designation Granted for VGT-1849A
VGT-1849A is a novel ASO treatment candidate for PV and other JAK2-driven hematologic malignancies.
Orphan Drug Designation | 21/12/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy